197 related articles for article (PubMed ID: 31879277)
21. Pneumococcal conjugate vaccine for young children.
Selman S; Hayes D; Perin LA; Hayes WS
Manag Care; 2000 Sep; 9(9):49-52, 54, 56-7 passim. PubMed ID: 11116663
[TBL] [Abstract][Full Text] [Related]
22. Adherence to pneumococcal conjugate vaccination schedule and uptake rate as compared to the established diphtheria-tetanus-acellular pertussis vaccination in Cyprus.
Hadjipanayis A; Efstathiou E; Michaelidou K; Papaevangelou V
Vaccine; 2018 Sep; 36(38):5685-5691. PubMed ID: 30115523
[TBL] [Abstract][Full Text] [Related]
23. Treatment with belimumab in systemic lupus erythematosus does not impair antibody response to 13-valent pneumococcal conjugate vaccine.
Nagel J; Saxne T; Geborek P; Bengtsson AA; Jacobsen S; Svaerke Joergensen C; Nilsson JÅ; Skattum L; Jönsen A; Kapetanovic MC
Lupus; 2017 Sep; 26(10):1072-1081. PubMed ID: 28420056
[TBL] [Abstract][Full Text] [Related]
24. A virtual clinic improves pneumococcal vaccination coverage among patients living with HIV at a Veterans Affairs Medical Center.
Burns CM; Banks RE; Wilson BM; Carter RR; Jump RLP; Perez F
AIDS Care; 2018 Feb; 30(2):146-149. PubMed ID: 29052434
[TBL] [Abstract][Full Text] [Related]
25. Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine administered to older infants and children naïve to pneumococcal vaccination.
Wysocki J; Brzostek J; Szymański H; Tetiurka B; Toporowska-Kowalska E; Wasowska-Królikowska K; Sarkozy DA; Giardina PC; Gruber WC; Emini EA; Scott DA
Vaccine; 2015 Mar; 33(14):1719-25. PubMed ID: 25698485
[TBL] [Abstract][Full Text] [Related]
26. Indirect (herd) protection, following pneumococcal conjugated vaccines introduction: A systematic review of the literature.
Tsaban G; Ben-Shimol S
Vaccine; 2017 May; 35(22):2882-2891. PubMed ID: 28449971
[TBL] [Abstract][Full Text] [Related]
27. Predictors of uptake of newly introduced vaccines in Malawi - monovalent human rotavirus and pneumococcal conjugate vaccines: Evidence from the 2015-16 Malawi demographic and health survey.
Ntenda PAM; Mwenyenkulu ET; Putthanachote N; Nkoka O; Mhone TG; Motsa MPS; Tizifa T
J Trop Pediatr; 2019 Jun; 65(3):287-296. PubMed ID: 30085260
[TBL] [Abstract][Full Text] [Related]
28. Vaccine effectiveness of the pneumococcal Haemophilus influenzae protein D conjugate vaccine (PHiD-CV10) against clinically suspected invasive pneumococcal disease: a cluster-randomised trial.
Palmu AA; Jokinen J; Nieminen H; Syrjänen R; Ruokokoski E; Puumalainen T; Moreira M; Schuerman L; Borys D; Kilpi TM
Lancet Respir Med; 2014 Sep; 2(9):717-27. PubMed ID: 25127244
[TBL] [Abstract][Full Text] [Related]
29. Effect of previous vaccination with pneumococcal conjugate vaccine on pneumococcal polysaccharide vaccine antibody responses.
Schaballie H; Wuyts G; Dillaerts D; Frans G; Moens L; Proesmans M; Vermeulen F; De Boeck K; Meyts I; Bossuyt X
Clin Exp Immunol; 2016 Aug; 185(2):180-9. PubMed ID: 26939935
[TBL] [Abstract][Full Text] [Related]
30. Could a single dose of pneumococcal conjugate vaccine in children be effective? Modeling the optimal age of vaccination.
Barzilay EJ; O'Brien KL; Kwok YS; Hoekstra RM; Zell ER; Reid R; Santosham M; Whitney CG; Feikin DR
Vaccine; 2006 Feb; 24(7):904-13. PubMed ID: 16203059
[TBL] [Abstract][Full Text] [Related]
31. A survey of systemic lupus erythematosus patients' attitudes toward influenza and pneumococcal vaccination in Southwest China.
Chen Y; Chen B; Shen X; Zhou A; Liang Y; Wang Y; Chen H
Front Public Health; 2022; 10():1018899. PubMed ID: 36605245
[TBL] [Abstract][Full Text] [Related]
32. [Serious invasive pneumococcal disease in young children: the importance of vaccination].
Haveman LM; Geelen SP; Sanders EA; Wolfs TF
Ned Tijdschr Geneeskd; 2002 Oct; 146(41):1917-20. PubMed ID: 12404904
[TBL] [Abstract][Full Text] [Related]
33. Call to action on pneumococcal disease: review of vaccination evidence and outcomes of webcast programs.
Grogg SE; Schultz J
J Am Osteopath Assoc; 2015 Jun; 115(6 Suppl):S6-25. PubMed ID: 26000904
[TBL] [Abstract][Full Text] [Related]
34. Effectiveness of the 7-valent pneumococcal conjugate vaccine in children with sickle cell disease in the first decade of life.
Adamkiewicz TV; Silk BJ; Howgate J; Baughman W; Strayhorn G; Sullivan K; Farley MM
Pediatrics; 2008 Mar; 121(3):562-9. PubMed ID: 18310206
[TBL] [Abstract][Full Text] [Related]
35. Pneumococcal 13-valent conjugate vaccine for the prevention of invasive pneumococcal disease in children and adults.
Gladstone RA; Jefferies JM; Faust SN; Clarke SC
Expert Rev Vaccines; 2012 Aug; 11(8):889-902. PubMed ID: 23002969
[TBL] [Abstract][Full Text] [Related]
36. Change in Pneumococcus Serotypes but not Mortality or Morbidity in Pre- and Post-13-Valent Polysaccharide Conjugate Vaccine Era: Epidemiology in a Pediatric Intensive Care Unit over 10 Years.
Hon KL; Chan KH; Ko PL; Cheung MHY; Tsang KYC; Chan LCN; Chan RWY; Leung TF; Ip M
J Trop Pediatr; 2018 Oct; 64(5):403-408. PubMed ID: 29126217
[TBL] [Abstract][Full Text] [Related]
37. Immunogenicity, safety and tolerability of anti-pneumococcal vaccination in systemic lupus erythematosus patients: An evidence-informed and PRISMA compliant systematic review and meta-analysis.
Adawi M; Bragazzi NL; McGonagle D; Watad S; Mahroum N; Damiani G; Conic R; Bridgewood C; Mahagna H; Giacomelli L; Eggenhöffner R; Mahamid M; Pigatto PDM; Amital H; Watad A
Autoimmun Rev; 2019 Jan; 18(1):73-92. PubMed ID: 30408581
[TBL] [Abstract][Full Text] [Related]
38. Immunogenicity and safety of pneumococcal vaccination in patients with rheumatoid arthritis or systemic lupus erythematosus.
Elkayam O; Paran D; Caspi D; Litinsky I; Yaron M; Charboneau D; Rubins JB
Clin Infect Dis; 2002 Jan; 34(2):147-53. PubMed ID: 11740700
[TBL] [Abstract][Full Text] [Related]
39. Declining serotype coverage of new pneumococcal conjugate vaccines relating to the carriage of Streptococcus pneumoniae in young children.
Tocheva AS; Jefferies JM; Rubery H; Bennett J; Afimeke G; Garland J; Christodoulides M; Faust SN; Clarke SC
Vaccine; 2011 Jun; 29(26):4400-4. PubMed ID: 21504773
[TBL] [Abstract][Full Text] [Related]
40. Impact of the pneumococcal conjugate vaccines on invasive pneumococcal disease in France, 2001-2012.
Lepoutre A; Varon E; Georges S; Dorléans F; Janoir C; Gutmann L; Lévy-Bruhl D; ;
Vaccine; 2015 Jan; 33(2):359-66. PubMed ID: 25448105
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
